Frequently Asked Questions:
The COVID-19 pandemic has had a major impact on the global autism spectrum disorder market, causing interruptions in supply chains, clinical trials, and patient access to care. However, the pandemic has highlighted the need for better diagnostic methods and therapies for autism, leading to increasing corporate investment in R&D activities.
In 2022, North America held the largest global autism spectrum disorder market share.
The increasing prevalence of autism spectrum disorder globally, increased awareness and early diagnosis, and rising demand for autism spectrum disorder therapies and services are the major drivers for the growth of the autism spectrum disorder market.
The autistic disorder segment had a major global market share in 2022.
The retail pharmacy segments had a major share in the global market.